Status:
COMPLETED
Non-analgesic Effects Produced by Equipotent Analgesic Doses of Sufentanil, Hydromorphone, and Oxycodone
Lead Sponsor:
Peking University People's Hospital
Conditions:
Opioid Use
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
This study aimed to investigate Non-analgesic Effects Produced by Equipotent Analgesic Doses of Sufentanil, Hydromorphone, and Oxycodone in female patients. Methods: A total of 60 patients were random...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists GradeⅠ-II;
- Patients undergo low-risk elective surgery for benign diseases (including laparoscopic ovarian cyst removal, laparoscopic tubal ligation, laparoscopic tubal drainage, breast operation, thyroid operation, etc) ;
- Aged 18-45 years;
- Body Mass Index 18-25kg/m2, weight 40-65 kilograms;
- Agreed to participate in the research
Exclusion
- Difficult airway;
- upper respiratory tract infection within 2 weeks;
- history of allergy or long-term use of propofol and opioids;
- self-rating anxiety scale before operation indicates anxiety;
- pregnancy or lactation.
Key Trial Info
Start Date :
May 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04396587
Start Date
May 20 2020
End Date
June 1 2023
Last Update
May 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100044